Peptoid Antibacterial Design for Selective Membrane Interaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Natural antimicrobial peptides face limitations in clinical use due to rapid in vivo degradation, leading to low bioavailability, and existing antimicrobial compounds often exhibit high cytotoxicity and hemolysis, limiting their effectiveness and selectivity against bacterial infections.
Innovation Solution
Development of poly-N-substituted glycine compounds, specifically peptoids, which are protease-resistant, easily synthesizable, and capable of forming amphipathic helices, offering broad-spectrum antibacterial activity with low mammalian cytotoxicity and negligible hemolysis, and can be tuned for optimal sequence and side chain functionality to enhance selectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural antimicrobial peptides are used to combat bacterial infections, then antibacterial activity is achieved, but rapid in vivo degradation occurs leading to low bioavailability
Solution Approach 1:
The patent creates peptoid copies that mimic the structure and function of natural antimicrobial peptides. These peptoids are poly-N-substituted glycines that replicate the amphipathic helical structure of AMPs, allowing them to interact with bacterial membranes in a similar manner while being resistant to proteolytic degradation, thus achieving both antibacterial activity and improved bioavailability
Solution Approach 2:
The patent modifies the chemical parameters of the peptide backbone by replacing the natural peptide bond with a poly-N-substituted glycine structure. This parameter change maintains the essential amphipathic properties and helical structure necessary for antibacterial activity while fundamentally altering the molecule to resist enzymatic degradation, thereby extending duration of action and improving bioavailability
2Reliability
If existing antimicrobial compounds are used to treat bacterial infections, then antibacterial efficacy is achieved, but high cytotoxicity and hemolysis limit their effectiveness and selectivity
Solution Approach 1:
The patent applies local quality by creating facially amphipathic structures where hydrophobic and cationic residues are segregated into specific regions of the helix. This local arrangement allows the peptoid to interact selectively with bacterial membranes (which are anionic) while minimizing interaction with and damage to mammalian cells (which are largely zwitterionic), thereby reducing cytotoxicity and hemolysis while maintaining antibacterial efficacy
Solution Approach 2:
The patent employs asymmetric sequence design with three-fold periodicity (X-Y-Z)n that creates an uneven distribution of charged and hydrophobic residues around the helical axis. This asymmetry generates distinct facial regions with different properties, enabling selective interaction with bacterial membranes while sparing mammalian cells, thus resolving the contradiction between efficacy and selectivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptoids demonstrate potent antibacterial activity in the low micromolar range against both Gram-positive and Gram-negative bacteria with reduced hydrophobicity, maintaining selectivity and efficacy, thus overcoming the limitations of natural antimicrobial peptides and existing compounds.
Implementation Method 1
peptoids can be driven to form stable helical secondary structures via periodic incorporation of bulky, α-chiral side chains
Implementation Method 2
Amphipathic secondary structures in which residues are segregated into hydrophobic and cationic regions are the hallmark of most AMPs
Implementation Method 3
The cationic region facilitates electrostatically driven adsorption to anionic bacterial membranes
Implementation Method 4
The hydrophobic region provides an additional driving force for incorporation of the AMP into the lipid bilayer
Data Source
AI summary
Antimicrobial peptoid compounds and related compositions as can be used against bacteria effectively and selectively.